1. Frei E Ill, Teicher BA, Holden SA, et al. Effect of alkylating agent dose: studies and possible clinical correlation, Cancer Res, 48 (1988) 6417–6432.
2. Teicher BA, Cucci CA, Lee JB, et al. Alkylating agents: in vitro studies of cross resistance patterns in human cell lines, Cancer Res, 46 (1986) 4379–4383.
3. Henderson IC, Hayes DF, and Gelman R. Dose-response in the treatment of breast cancer: a critical review, J. Clin. Oncol., 6 (1988) 1501–1515.
4. Hyrniuk W and Bush H. Importance of dose intensity in chemotherapy of metastatic breast cancer, J. Clin. Oncol., 2 (1984) 1281–1288.
5. Peters WP, Eder JP, Henner WP, et al. High-dose combination alkylating agents with autologous bone marrow support: a phase I study, J. Clin. Oncol., 4 (1986) 646–654.